Alan Boyd Email & Phone Number

I began my 30 years’ pharmaceutical career with Glaxo Group Research Ltd. From 1988 I led ICI’s cardiovascular medical research team, later assuming the role of Director of Clinical and Medical Affairs at ICI Pharma, Canada. In 1999, after four years as Head of Medical Research for Zeneca Pharmaceuticals, I became Director of Research and Development for Ark Therapeutics Ltd where I was responsible for delivering the majority of key development milestones that have shaped the company. In particular I led the development of their gene based medicines portfolio.In April 2005, I left to set up Boyd Consultants. The focus of which is to aid and support early stage life-science based companies and groups in Universities who have medicine based R&D projects. Our clients now include many organisations and companies in Europe, North America and Japan who are devoted to the development of medicines.A graduate in Biochemistry and Medicine from the University of Birmingham, UK, I am also a Fellow, Board Member and Chair of the Specialist Advisory Committee in Pharmaceutical Medicine at the Faculty of Pharmaceutical Medicine, Royal College of Physicians, United Kingdom. I was elected Vice-President of the Faculty in November 2012.In November 2009 I was appointed an Honorary Professor in the College of Medical and Dental Sciences at the University of Birmingham Medical School, in recognition of his expertise in medicines development.

Listed skills include Clinical Trials, Pharmaceutical Industry, Clinical Research, Clinical Development, and 24 others.

• 

  Ceo

  Boyd'S

  May 2005 - Present - Crewe, Cheshire, Gb